Safe Use Of Hydrogen-Peroxide Contact Lens Solution Magnified in US FDA Draft Guidance
Draft guidance pulls from Ophthalmic Devices Panel and Risk Communication Advisory Committee 2017 meeting to discuss more clearly communicating risks of the solutions to consumers while allowing products to remain available OTC.
You may also be interested in...
FDA advisory panel members found few easy solutions to the risk posed by contact lens solutions containing hydrogen peroxide, but agreed clearer and more consistent labeling is needed.
Submitting other OTC monograph program communications through CDER's NextGen Portal, including proposals to add formulations or indications to a monograph, will have to wait.
FDA approves warning for severe cutaneous adverse reactions on labeling for Perrigo's 131 20-mg omeprazole delayed-release tablet products across unflavored and cool mint or wild berry-mint options and 14-, 28- and 42-count packages.